| 26th Aug 2021 7:00 am |
RNS |
Peer reviewed publication |
| 13th Aug 2021 11:49 am |
RNS |
Director/PDMR Shareholding |
| 6th Aug 2021 4:42 pm |
RNS |
Director/PDMR Dealing |
| 2nd Aug 2021 12:00 pm |
RNS |
Total Voting Rights |
| 30th Jul 2021 4:25 pm |
RNS |
Director/PDMR Dealing |
| 28th Jul 2021 7:00 am |
RNS |
Appointment of Ann Berman to Board of Directors |
| 23rd Jul 2021 11:30 am |
RNS |
Director/PDMR Shareholding |
| 22nd Jul 2021 7:00 am |
RNS |
VP of Global Quality and Regulatory Appointment |
| 19th Jul 2021 3:02 pm |
RNS |
Exercise of Options and TVR |
| 7th Jul 2021 7:00 am |
RNS |
Exercise of options, PDMR transaction and TVR |
| 1st Jul 2021 3:51 pm |
RNS |
Directorate Change |
| 1st Jul 2021 7:00 am |
RNS |
Total Voting Rights |
| 28th Jun 2021 11:50 am |
RNS |
Director/PDMR Shareholding |
| 28th Jun 2021 7:00 am |
RNS |
New data for KidneyIntelX |
| 25th Jun 2021 5:25 pm |
RNS |
Director/PDMR Dealing |
| 25th Jun 2021 12:52 pm |
RNS |
Exercise of options |
| 24th Jun 2021 2:00 pm |
RNS |
Change of name |
| 22nd Jun 2021 1:25 pm |
RNS |
Director/PDMR Shareholding - Replacement |
| 22nd Jun 2021 10:57 am |
RNS |
Director/PDMR Shareholding |
| 15th Jun 2021 7:00 am |
RNS |
Financial Results for Third Quarter of FY 2021 |
| 10th Jun 2021 7:00 am |
RNS |
Notice of Results & Change of Auditor |
| 7th Jun 2021 7:00 am |
RNS |
Key new hires to drive commercialization strategy |
| 3rd Jun 2021 7:00 am |
RNS |
Utility Study |
| 25th May 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st May 2021 7:02 am |
RNS |
Director/PDMR Dealing |
| 19th May 2021 8:00 am |
RNS |
Partnership |
| 22nd Apr 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 22nd Apr 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 22nd Apr 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 22nd Apr 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 22nd Apr 2021 7:00 am |
RNS |
10-year US Government contract award |
| 20th Apr 2021 7:00 am |
RNS |
Positive clinical outcome data for KidneyIntelX |
| 19th Apr 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
| 14th Apr 2021 7:00 am |
RNS |
Exclusive option agreement |
| 8th Apr 2021 7:00 am |
RNS |
Clinical Utility Study |
| 6th Apr 2021 7:00 am |
RNS |
Clinical findings published in Diabetologia |
| 15th Mar 2021 7:00 am |
RNS |
Update on Finalization of MCIT Rule |
| 4th Mar 2021 6:00 pm |
RNS |
Issue of shares, PDMR Dealing and TVR |
| 2nd Mar 2021 7:02 am |
RNS |
Financial Results for Second Quarter of FY 2021 |
| 2nd Mar 2021 7:00 am |
RNS |
Half-year Report |
